Peritoneal Carcinomatosis — Trials

Peritoneal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 42
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: University of California, Irvine
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06084780	Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)(TRANSCAPE)	not yet recruiting	Phase 2	20	Case Comprehensive Cancer CenterOTHER	1	Sep 24, 2026	clinicaltrials
NCT07593261	MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).(MARACAS)	not yet recruiting	Phase 2	34	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER